Renvela is a prescription medication that contains Sevelamer Carbonate as the active ingredient. It is manufactured by Genzyme Pharmaceuticals Ltd and comes in the form of tablets. The medication is used to control high blood phosphate levels in patients with chronic kidney disease.
Renvela is primarily used for the treatment of hyperphosphatemia (high blood phosphate levels) in patients with chronic kidney disease who are on dialysis. It works by binding to phosphates in the diet, which prevents their absorption in the body and helps to reduce the levels of phosphates in the blood.
How to Use:
Renvela should be taken as directed by the healthcare provider. The tablets should be swallowed whole with water and should not be chewed or crushed. The dosage and duration of treatment may vary depending on the patient’s condition and response to the treatment.
Renvela tablets should be stored at room temperature, away from direct sunlight and moisture. It should be stored out of the reach of children and pets. The medication should be used before the expiration date mentioned on the packaging.
Mechanism of Action:
Sevelamer Carbonate, the active ingredient in Renvela, works by binding to dietary phosphates in the gut, which prevents their absorption into the bloodstream. This helps to reduce the levels of phosphates in the blood, which can prevent complications in patients with chronic kidney disease who are on dialysis.
Before taking Renvela, it is important to inform the healthcare provider about any known allergies, medical conditions, or medications currently being taken. Patients with a history of bowel obstruction or severe constipation should be carefully monitored while taking this medication.
Renvela is contraindicated in patients who have bowel obstruction or a history of bowel obstruction. It should not be used in individuals who have a history of severe constipation, hypophosphatemia (low blood phosphate levels), or who are allergic to Sevelamer Carbonate or any other components of the medication.
Renvela may interact with certain medications, such as ciprofloxacin and levothyroxine. It is important to inform the healthcare provider about all medications being taken to avoid potential drug interactions.
In case of an overdose of Renvela, immediate medical attention should be sought. The symptoms of overdose may include severe stomach pain, vomiting, and diarrhea.
Common side effects of Renvela include nausea, vomiting, and diarrhea. Other less common side effects may include constipation, abdominal pain, and flatulence. It is important to seek medical advice if any severe or persistent side effects occur.